5 February 2025 Argent BioPharma Ltd.
[...]
This is an abstract of the document. To keep reading, click here and get access to the original version.
Corporate Update - Board Change
Story so far
Earlier from Argent Biopharma
- Placing to Raise US$4,500,000
- Trading Halt
- ASX Listing Update
- Placing to Raise A$200,000
- Preliminary Final Report
Later from Argent Biopharma
- Half Year Accounts
- Strategic Manufacturing Partnership with ECCPharm Limited
- Exclusive Agreement for Malta Manufacturing Facility
- Argent BioPharma Expands Pipeline with Promising Drug CimetrA®
- CimetrA Phase IIb Clinical Trial Results
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma